These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8230980

  • 1. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M, Chotkowska E, Peczkowska M, Sawicki M, Janaszek-Sitkowska H, Wiernikowska-Wegorek I, Galewicz A, Cybulska I.
    Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [Abstract] [Full Text] [Related]

  • 4. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC.
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [Abstract] [Full Text] [Related]

  • 5. [Doxazosin for the treatment of arterial hypertension].
    Mozzato MG, Semplicini A, Serena L, Valle R, Casolino P, Buzzaccarini F, Rubino N, Giusto M, Pessina AC.
    Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
    [Abstract] [Full Text] [Related]

  • 6. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C, Gil-Extremera B, Gomez-Fernández P, Masramon X, Pueyo C, Armada B.
    Int J Cardiol; 2005 May 11; 101(1):97-104. PubMed ID: 15860390
    [Abstract] [Full Text] [Related]

  • 7. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
    Toth K, Nemes J, Czopf L, Kapronczay P, Kesmarky G, Juricskay I.
    Clin Hemorheol Microcirc; 1999 May 11; 20(1):57-61. PubMed ID: 11185685
    [Abstract] [Full Text] [Related]

  • 8. [The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
    Daae LN, Kierulf P, Brusletto B, Westheim A, Holme I, Syvertsen JO.
    Tidsskr Nor Laegeforen; 1991 Apr 10; 111(9):1102-5. PubMed ID: 1827216
    [Abstract] [Full Text] [Related]

  • 9. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K, Kesmarky G, Vekasi J, Nemes J, Czopf L, Kapronczay P, Halmosi R, Papp E, Juricskay I.
    Clin Hemorheol Microcirc; 1999 Apr 10; 21(3-4):209-16. PubMed ID: 10711745
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of essential arterial hypertension with hypercholesterolemia. Effects of an alpha-adrenergic blocker and an inhibitor of the angiotensin converting enzyme].
    Fernández Pinilla C, Luque Otero M, Martell Claros N, Alcázar de la Osa JM, Rodicio Díaz JL, Ruilope Urioste LM.
    Med Clin (Barc); 1993 Jun 26; 101(5):168-71. PubMed ID: 8332009
    [Abstract] [Full Text] [Related]

  • 11. Combined effect of a low fat diet and doxazosin on blood pressure control and blood lipids. Hunter Hypertension Research Group.
    J Hum Hypertens; 1994 Dec 26; 8(12):907-10. PubMed ID: 7884789
    [Abstract] [Full Text] [Related]

  • 12. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE, Johansson J, Berne C, Lithell H.
    J Hum Hypertens; 1994 Mar 26; 8(3):219-26. PubMed ID: 8006923
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr 26; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age].
    Calvo C, López E, Barrio E, Espejo J, Ruiz M, Vega A.
    An Med Interna; 1995 Mar 26; 12(3):122-6. PubMed ID: 7795118
    [Abstract] [Full Text] [Related]

  • 15. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Mar 26; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 16. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar 26; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 17. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin].
    Hitzenberger G, Ganzinger U.
    Wien Klin Wochenschr; 1993 Mar 26; 105(13):371-6. PubMed ID: 8351927
    [Abstract] [Full Text] [Related]

  • 18. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T, Gomi T, Shibuya Y, Shinozaki S, Suzuki Y, Matsuda N.
    Hypertens Res; 2007 Nov 26; 30(11):1097-105. PubMed ID: 18250559
    [Abstract] [Full Text] [Related]

  • 19. Doxazosin in hypertension: results of a general practice study in 4809 patients.
    Langdon CG, Packard RS.
    Br J Clin Pract; 1994 Nov 26; 48(6):293-8. PubMed ID: 7848789
    [Abstract] [Full Text] [Related]

  • 20. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Nov 26; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.